Marisa Haenni
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (33)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
The increase in the infection caused by Acinetobacter baumannii is sustained by the selection of distinct epidemic clonal lineages, which are frequently resistant to a broad range of antimicrobials and possess virulence traits responsible for their persistence in the contaminated environment and spread among patients. The present study aimed to perform an integrated genomic and phenotypic analysis to assess the virulence features of ST25 isolates. A. baumannii isolates assigned to the ST25 epidemic clonal lineage shared high genomic similarity and clustered in four clades (I, II, III, and IV), with clade IV further subdivided into CIVa, CIVb, CIVc, and CIVd. Capsular locus (KL) KL14 was the predominant KL type (47%). Accessory genome analysis showed the presence of tartrate metabolism genes only in CII genomes. CIVb and CIVd ST25 A. baumannii isolates showed higher ability to infect Galleria mellonella larvae than CI, CII, CIII, and CIVc isolates. Hydrogen peroxide resistance was higher in CI, CII, CIVb, and CIVd isolates compared with CIII and CIVc isolates. In desiccation survival tests, CIII, CIVb, and CIVd isolates exhibited prolonged survival. In addition, CI, CII, CIII, CIVb, and CIVd isolates showed higher serum resistance than CIVc isolates. Also, KL14 type and lipooligosaccharide outer core locus (OCL) OCL6 type isolates were significantly more resistant to oxidative stress, to desiccation, and possessed a high ability to kill G. mellonella larvae. A positive and significant correlation was found between AdeB and AdeJ efflux pump expression and hydrogen peroxide resistance. IMPORTANCE In this study, we characterized the genotypic and phenotypic features of A. baumannii strains assigned to the ST25 epidemic clonal lineage, which were isolated from humans, animals, and the environment. We found that ST25 A. baumannii isolates, irrespective of their antimicrobial resistance, showed peculiar virulence features among clades, isolates assigned to clade IVb and IVd showing the highest virulence and elevated resistance to serum and desiccation. Also, a positive significant correlation was found between the presence of KL14 and outer core locus 6 genotypes and resistance to oxidative stress, resistance to desiccation, and the ability to kill G. mellonella larvae. Phenotypic differences reflected clade identity rather than isolate origin, suggesting that specific virulence traits contribute to the environmental persistence and pathogenic potential of A. baumannii ST25 isolates.
Year:
2026
Background ‘One Health’ initiatives to tackle the rising risk of antimicrobial resistance (AMR) have flourished due to increasing detection of Enterobacterales producing extended-spectrum beta-lactamases (ESBLs) and carbapenemases (CPs). Objectives This study aimed to conduct an in-depth holistic analysis of Escherichia coli (Ec) and Klebsiella pneumoniae (Kp) isolates recovered from landfill-foraging white stork faecal samples and clinical isolates from a nearby hospital. Methods Faecal samples (n = 211) were collected from storks foraging at two landfills in Spain. Ec/Kp stork isolates were recovered on selective media and whole-genome sequencing (WGS), together with isolates obtained from the nearby hospital. These genomic data were compared with public genomes from different contexts (clinical, environmental, or animal hubs) to understand global transmission dynamics. Results A wide range of blaESBL/blapAmpC (blaCTX-M/blaSHV-12/blaDHA) were detected in 71 stork samples (33.6%), while blaCP (blaKPC/blaNDM/blaOXA-48/blaVIM) were identified in 28 (13.3%) samples. Clonal and plasmid transmissions were evidenced inside and between both landfills. Mapping against 10 624 public Ec/Kp genomes and from those of nearby hospital revealed that identical strains (<10 allelic differences with Ec-ST38/ST131 and Kp-ST512 lineages) and epidemic plasmids (full identity/coverage with IncN/blaKPC-2, IncF/blaKPC-3, IncX3/blaNDM-7, IncL/blaOXA-48) were found from clinical isolates in countries located along the storks’ migration routes. Conclusions Storks may be contaminated by bacterial isolates from a likely human origin and become non-human reservoirs of critical genes, which can be dispersed over long distances. Identifying strains/plasmids along the stork’s routes that are identical or closely related to those described here opens new perspectives for large-scale research to understand the AMR transmission dynamics.
Year:
2025
Amoxicillin-clavulanic acid (AMC) is an important antibiotic in human and veterinary medicine. However, it can select antibiotic-resistant bacteria in the gut microbiota and alter its composition. In calves, AMC can be used to treat complicated infections. The impact of AMC on the calves’ gut is unknown; thus, we analyzed the effect of a five-day AMC treatment in veal calves suffering from omphalitis. AMC-treated calves ( n = 15) and a control untreated group ( n = 15) were enrolled from two farms. Stools were collected before AMC administration (D0), one day (D6), one month (D35), and two months (D55) after AMC withdrawal. The effect of AMC treatment on gut microbiota composition and resistance gene selection was analyzed by full-length 16S rRNA operon sequencing and qPCR, respectively. Selection of Extended-Spectrum Cephalosporin-Resistant (ESC-R) Escherichia coli in calf’s fecal samples and dissemination in the farms’ environment were analyzed by cultivation and genome sequencing of isolates. After AMC treatment, alpha-diversity decreased in AMC-treated calves along with a decrease of the relative abundance of bacterial families beneficial for host health (Lachnospiraceae) and an increase of Pseudomonadota, grouping opportunistic pathogens. ESC-R E. coli carriage dynamics were different between calves sampled from each farm and seemed independent from AMC treatment. Besides, calves received other antibiotics that could have an impact on resistance selection. Certain clones of ESC-R E. coli demonstrated a widespread dissemination in the farm, both in calves hosted in distant zones and in their environment. To decrease the antibiotic resistance burden, it is essential to use antibiotics judiciously, alongside improving hygienic practices in farms. IMPORTANCE Antibiotic therapies can select resistant bacteria in the gut of treated hosts and deplete bacteria that are beneficial to the host health. Antibiotic-resistant bacteria selected in the gut of food-producing animals, like veal calves, are excreted and can then disseminate among animals, to the environment (through manure or water contamination) and to farmers who may further disseminate these organisms to other people in contact. Antibiotic resistance genes can disseminate among clones present in the gut of both animal and human hosts by horizontal gene transfer. Studying the impact of antibiotic therapies on the gut microbiota has One Health relevance. Thus, we aimed to (i) analyze the impact of AMC treatment on the selection of resistant bacteria in the calf gut and its composition and (ii) analyze the dissemination resistance in farms in order to advise on potential strategies to counteract further spread of these microorganisms.
Year:
2025
Objectives In France, a 10 year national policy to reduce antibiotic use (ABU) in animals led, respectively, to an 88% and 94% decrease in animal exposure to fluoroquinolones and third- and fourth-generation cephalosporins (3GC-4GC) between 2011 and 2021. Methods Building on national surveillance data, this study evaluated the impact of this national policy on reducing the occurrence of resistance to fluoroquinolones and 3GC-4GC in clinical Escherichia coli from young cattle and dogs and cats in France. The effect of homologous and heterologous use of antibiotics was explored using multivariate regression modelling. In addition, the time lag between implementation of national policies and subsequent reduction in antibiotic resistance (ABR) was estimated using segmented regression analysis. Results Statistical analysis of available ABU and ABR surveillance data demonstrated a significant and sustainable impact on the occurrence of resistance to fluoroquinolones in clinical E. coli (in cattle and in dogs and cats), and to a lesser extent to 3GC-4GC (in cattle). The effects were fast and observed within 1 (in cattle) or 2 years (in dogs and cats) after the implementation of the 2014 national policy targeting specifically the animals’ exposure to 3GC-4GC and fluoroquinolones. Conclusions The French 10 year national policy had a successful impact on the occurrence of resistance to fluoroquinolones and 3GC-4GC in clinical E. coli. A potential shift in ABU from the use of fluoroquinolones and 3GC-4GC to other antibiotic classes, such as trimethoprim/sulfonamides (since 2012), and penicillins and tetracyclines (since 2016), was also observed.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (63)
MARC MARENDA
senior lecturer
University of Melbourne
Paul Turner
University of Oxford
Ørjan Samuelsen
Professor
UiT The Arctic University of Norway
Helena Seth-Smith
Co-Leader of Microbial Genomics Devision
University of Zurich
Nicole Stoesser
Associate Professor
University of Oxford
Maria Stabile
Università degli Studi di Napoli Federico II
Amy Mathers
Professor
University of Virginia
Michael Bachman
Assistant Professor
University of Michigan
francesco pomilio
Head of Unit
Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche
Raffaele Zarrilli
Director of the program of Epidemiology and Prevention of Health Care Associated Infections
University of Naples Federico II
Sandra Reuter
Research Group Leader
University Medical Center Freiburg
Benjamin P. Howden
-
Koji Yahara
Group Leader
National Institute of Infectious Diseases
Arnfinn Sundsfjord
-
Alexandra Chiaverini
Ricercatore Sanitario (Cat. DS6) Veterinario
Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche
Sam Lipworth
University of Oxford
Peter Panduro Damborg
Københavns Universitet
Andrew McArthur
Professor
McMaster University
M. Estée Török
University of Cambridge
Charlene Rodrigues
Assistant Professor in Microbial Genomics
London School of Hygiene & Tropical Medicine
Caroline Prouillac
Enseignant chercheur
VetAgro Sup
Adrian Egli
Professor
University of Zurich
Kathryn Holt
Professor (Research)
MONASH UNIVERSITY
Leah Wendy Roberts
Queensland University of Technology
Daniela Maria Cirillo
Head of Unit
Ospedale San Raffaele
Tommaso Giani
Associate Professor
University of Florence
Glenn Browning
Director and Redmond Barry Distinguished Professor
University of Melbourne
Teresa M. Coque
-
Eliana De Gregorio
Prof
University of Naples Federico II
Marianne Sunde
Norwegian Veterinary Institute
Philippe Glaser
Head of research unit
Institut Pasteur
Gian Maria Rossolini
Professor
University of Florence
Thierry Naas
Prof
Assistance Publique - Hôpitaux de Paris
Jukka Corander
University of Oslo
Henok Ayalew Tegegne
Baylor College of Medicine
Motoyuki Sugai
-
Susana Campino
London School of Hygiene & Tropical Medicine
Iren H. Löhr
Stavanger University Hospital
D. Sassera
University of Pavia
Stephen Baker
University of Cambridge School of Clinical Medicine
Kelly L Wyres
MONASH UNIVERSITY
Andrea Spitaleri
Researcher
Human Technopole
Steven P Djordjevic
Research Theme Lead/Distinguished Professor
University of Sydney
Norelle Sherry
Deputy Director
University of Melbourne
Michael Brouwer
Utrecht University
MIDELET Graziella
Head of Unit
-
Ursula Höfle
Profesor Contratado Doctor
University of Castilla-La Mancha
Eva Heinz
Senior Lecturer
University Of Strathclyde
Melese Hailu Legese
Lecturer
Uppsala Universitet Uppsala biomedicinska centrum
Agnese LUPO
University of Lyon
Sylvain Brisse
Université Paris Cité
Edward Feil
Professor at Department of Life Sciences
University of Bath
Patrick N. A. Harris
University of Queensland
Taane Clark
Professor of Genomics and Global Health
London School of Hygiene & Tropical Medicine
Claire Gorrie
University of Melbourne
Carmen Torres
Professor of Biochemistry and Molecular Biology
University of La Rioja
Joao Perdigao
Professor do ensino Básico e Secundário
Ministério da Educação
Shizuo Kayama
National Institute of Infectious Diseases
Keith Jolley
Bioinformatician
University of Oxford
Nicholas Thomson
Head of Programme
Wellcome Sanger Institute
Harry Thorpe
University of Oslo
Nicholas Feasey
Professor
Liverpool School of Tropical Medicine
David Aanensen
Professor
University of Oxford
Make your next move.
Prepare your application
Review drafts before you send them.